Literature DB >> 28288782

Exosomes: a new horizon in lung cancer.

Irene Vanni1, Angela Alama2, Francesco Grossi1, Maria Giovanna Dal Bello1, Simona Coco1.   

Abstract

Circulating exosomes are the major mediators of cell-cell communication. They have been found in various body fluids of healthy individuals and patients with malignancies as cargos of several molecules including miRNAs. Several studies have underlined the role of exosome miRNAs in different tumor types, including lung cancer, suggesting their potential use as biomarkers and therapeutic agents. An overview of the biology and function of exosomes and exosome miRNAs as indicators of diagnosis and treatment response in lung cancer is presented. In addition, preliminary data on exosomes as potential therapeutic agents are reported.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28288782     DOI: 10.1016/j.drudis.2017.03.004

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  40 in total

1.  High-Metastatic Melanoma Cells Promote the Metastatic Capability of Low-Metastatic Melanoma Cells via Exosomal Transfer of miR-411-5p.

Authors:  Hao Chen; Bin Zeng; Xiaoshuang Li; Qiting Zhao; Doudou Liu; Yuting Chen; Yuhan Zhang; Jianyu Wang; H Rosie Xing
Journal:  Front Oncol       Date:  2022-05-20       Impact factor: 5.738

2.  Orthologs of human circulating miRNAs associated with hepatocellular carcinoma are elevated in mouse plasma months before tumour detection.

Authors:  Liang-Hao Ding; Christina M Fallgren; Yongjia Yu; Maureen McCarthy; Elijah F Edmondson; Robert L Ullrich; Michael M Weil; Michael D Story
Journal:  Sci Rep       Date:  2022-06-28       Impact factor: 4.996

3.  Circular RNA 0006602 in plasma exosomes: a new potential diagnostic biomarker for hepatocellular carcinoma.

Authors:  Sen Guo; Chunxiao Hu; Xiangyu Zhai; Dong Sun
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

Review 4.  Advances of exosome isolation techniques in lung cancer.

Authors:  Elham O Mahgoub; Ehsan Razmara; Amirreza Bitaraf; Fahimeh-Sadat Norouzi; Maryam Montazeri; Roudabeh Behzadi-Andouhjerdi; Mojtaba Falahati; Ke Cheng; Yousif Haik; Anwarul Hasan; Sadegh Babashah
Journal:  Mol Biol Rep       Date:  2020-08-12       Impact factor: 2.316

Review 5.  Research progress on exosomal proteins as diagnostic markers of gastric cancer (review article).

Authors:  Hang Su; Weihong Ren; Dai Zhang
Journal:  Clin Exp Med       Date:  2022-01-22       Impact factor: 3.984

Review 6.  Liquid Biopsy and Therapeutic Targets: Present and Future Issues in Thoracic Oncology.

Authors:  Paul Hofman
Journal:  Cancers (Basel)       Date:  2017-11-10       Impact factor: 6.639

7.  Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.

Authors:  Simona Coco; Angela Alama; Irene Vanni; Vincenzo Fontana; Carlo Genova; Maria Giovanna Dal Bello; Anna Truini; Erika Rijavec; Federica Biello; Claudio Sini; Giovanni Burrafato; Claudia Maggioni; Giulia Barletta; Francesco Grossi
Journal:  Int J Mol Sci       Date:  2017-05-11       Impact factor: 5.923

Review 8.  Biogenesis, Membrane Trafficking, Functions, and Next Generation Nanotherapeutics Medicine of Extracellular Vesicles.

Authors:  Sangiliyandi Gurunathan; Min-Hee Kang; Muhammad Qasim; Khalid Khan; Jin-Hoi Kim
Journal:  Int J Nanomedicine       Date:  2021-05-18

Review 9.  Exosome Traceability and Cell Source Dependence on Composition and Cell-Cell Cross Talk.

Authors:  Rabab N Hamzah; Karrer M Alghazali; Alexandru S Biris; Robert J Griffin
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

Review 10.  The dawn of the liquid biopsy in the fight against cancer.

Authors:  Irma G Domínguez-Vigil; Ana K Moreno-Martínez; Julia Y Wang; Michael H A Roehrl; Hugo A Barrera-Saldaña
Journal:  Oncotarget       Date:  2017-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.